Medical algorithm: Management of C1 inhibitor hereditary angioedema

Allergy. 2022 Mar;77(3):1060-1063. doi: 10.1111/all.15115. Epub 2021 Oct 22.

Authors

Teresa Caballero^{1

2

3

4}, Rosario Cabañas^{1

2

3

4

5}, María Pedrosa^{1

2

3

4}

Affiliations

¹ Allergy Department, Hospital Universitario La Paz, Madrid, Spain.
² Hospital La Paz Institute for Health Research (IdiPaz), Madrid, Spain.
³ Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain.
⁴ Grupo Español de estudio del Angioedema mediado por Bradicinina (GEAB), Madrid, Spain.
⁵ PIELenRed Consortium, Madrid, Spain.

PMID: 34587298
DOI: 10.1111/all.15115

No abstract available

Publication types

News

MeSH terms

Algorithms
Angioedemas, Hereditary* / diagnosis
Angioedemas, Hereditary* / drug therapy
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein / genetics
Complement C1 Inhibitor Protein / therapeutic use
Humans

Substances

Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein